Real-World Effectiveness, Adherence, and Persistence among Patients with T2DM Initiating Dulaglutide

被引：0
|
作者：
Mody, Reema
Grabner, Michael
Yu, Maria
Turner, Ralph
Kwan, Anita
York, Whitney
Lando, Laura Fernandez
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1327-P
引用
收藏
页码：A355 / A355
页数：1
相关论文
共 50 条
  • [31] Real-World Risk Indicators of Impaired Awareness of Hypoglycemia in T2DM (InHypo-DM Study)
    Ratzki-Leewing, Alexandria
    Harris, Stewart B.
    Au, Natalie H.
    Webster-Bogaert, Susan
    Brown, Judith B.
    Reichert, Sonja M.
    Ryan, Bridget L.
    DIABETES, 2019, 68
  • [32] ASSESSING ADHERENCE TO SGLT2 INHIBITOR ADD-ON TO METFORMIN THERAPY IN CHINESE T2DM PATIENTS: A REAL-WORLD RETROSPECTIVE COHORT STUDY
    Bao, H.
    Jian, Y.
    Peng, X.
    Xuan, J.
    VALUE IN HEALTH, 2024, 27 (06) : S308 - S308
  • [33] MEDICATION UTILIZATION PATTERNS AMONG T2DM PATIENTS INITIATING TREATMENT WITH ORAL SEMAGLUTIDE
    Frazer, M.
    Swift, C.
    Sargent, A.
    Leszko, M.
    Buysman, E. K.
    Alvarez, S.
    Noone, J.
    Guevarra, M.
    VALUE IN HEALTH, 2023, 26 (06) : S255 - S255
  • [34] REAL-WORLD INCIDENCE OF HYPOGLYCEMIA AND ASSOCIATED COSTS AMONG INSULIN GLARGINE-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Xie, L.
    Wei, W.
    Pan, C.
    Baser, O.
    VALUE IN HEALTH, 2012, 15 (07) : A493 - A493
  • [35] Real-World Persistence with GLP-1 RA Treatment in Patients with Type 2 Diabetes Mellitus (T2DM) and Advanced Chronic Kidney Disease (CKD)
    Sidra, Fnu
    Xie, Donglu
    Agarwal, Shubham
    Lingvay, Ildiko
    DIABETES, 2023, 72
  • [36] Real-World (RW) treatment patterns in patients with T2DM newly initiated with antihyperglycemic (AHA) medications in the US
    Cai, Jennifer
    Burudpakdee, Chakkarin
    Divino, Victoria
    Fegade, Mayuresh
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S117 - S117
  • [37] Adherence and persistence to ocrelizumab in a real-world cohort
    Rodriguez Regal, Ana
    Lopez Real, Ana Maria
    Alvarez Rodriguez, Elena
    Garcia-Estevez, Daniel Apolinar
    Rodriguez Rodriguez, Maria
    Pato, Antonio
    Costa, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1014 - 1014
  • [38] Efficacy by Baseline BMI with Once Weekly Dulaglutide in Chinese T2DM Patients
    Shi, Yongquan
    Zhang, Bin
    Wu, Haiya
    DIABETES, 2019, 68
  • [39] Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12-month follow-up in a real-world setting in the United States
    Mody, Reema
    Huang, Qing
    Yu, Maria
    Zhao, Ruizhi
    Patel, Hiren
    Grabner, Michael
    Lando, Laura Fernandez
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 920 - 929
  • [40] MEDICATION USE AMONG T2DM PATIENTS INITIATING TREATMENT WITH ONCE WEEKLY (OW) SEMAGLUTIDE
    Frazer, M.
    Swift, C.
    Sargent, A.
    Leszko, M.
    Buysman, E. K.
    Alvarez, S.
    Noone, J.
    Gamble, C.
    VALUE IN HEALTH, 2023, 26 (06) : S246 - S246
12345